The Journal of invasive cardiology · 2026
Right internal jugular implantation of the AVEIR leadless pacemaker: a case series demonstrating feasibility and safety.
СтатьяКлинический случайНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pourafkari Leili, Kim Jeong Hwan J, Sovari Ali
Аннотация
OBJECTIVES: Leadless pacemakers provide an alternative to transvenous pacing in patients at risk for lead- and pocket-related complications. While the femoral vein is the standard route of implantation, certain anatomical or clinical factors may make this approach technically challenging. The objective of this study was to evaluate the feasibility and safety of AVEIR (Abbott) implantation through the right internal jugular (RIJ) vein in patients in whom the femoral approach was not feasible.
METHODS: The authors report a single-center case series of patients who underwent AVEIR implantation using the RIJ vein. Procedural techniques, periprocedural management, and early clinical outcomes were reviewed.
RESULTS: Eight patients (8 VR and 1 DR) underwent successful implantation through the RIJ approach. Device deployment was accomplished with stable electrical parameters and without acute complications.
CONCLUSIONS: This case series demonstrates that AVEIR implantation via the RIJ is both technically feasible and safe. These findings expand access strategies for leadless pacing and may provide a foundation for future applications of conduction system pacing using superior venous routes.
METHODS: The authors report a single-center case series of patients who underwent AVEIR implantation using the RIJ vein. Procedural techniques, periprocedural management, and early clinical outcomes were reviewed.
RESULTS: Eight patients (8 VR and 1 DR) underwent successful implantation through the RIJ approach. Device deployment was accomplished with stable electrical parameters and without acute complications.
CONCLUSIONS: This case series demonstrates that AVEIR implantation via the RIJ is both technically feasible and safe. These findings expand access strategies for leadless pacing and may provide a foundation for future applications of conduction system pacing using superior venous routes.